Paper42840552PubMed
Neuroimmune responses in neonatal hypoxic-ischemic encephalopathy: cellular roles, crosstalk, and therapeutic opportunities.
He S and 2 others. Front Pediatr, 2026.
Cite this record
ConductScience Library. Neuroimmune responses in neonatal hypoxic-ischemic encephalopathy: cellular roles, crosstalk, and therapeutic opportunities. Papers, record 42840552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42840552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuroimmune responses in neonatal hypoxic-ischemic encephalopathy: cellular roles, crosstalk, and therapeutic opportunities.
- Journal
- Front Pediatr
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-08
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41469822 | Sildenafil reduced neuroinflammation and improved white matter injury in a rat model of term neonatal hypoxic-ischemic encephalopathy. | Sci Rep | 2025 | https://conductscience.org/library/papers/41469822 | PubMed |
| 2 | 32761315 | IRF5 Signaling in Phagocytes Is Detrimental to Neonatal Hypoxic Ischemic Encephalopathy. | Transl Stroke Res | 2021 | https://conductscience.org/library/papers/32761315 | PubMed |
| 3 | 34836132 | Dose-Dependent Neuroprotective Effects of Bovine Lactoferrin Following Neonatal Hypoxia-Ischemia in the Immature Rat Brain. | Nutrients | 2021 | https://conductscience.org/library/papers/34836132 | PubMed |
| 4 | 37797337 | Neonatal Hypoxic-Ischemic Encephalopathy and Hypothermia Treatment. | Obstet Gynecol | 2024 | https://conductscience.org/library/papers/37797337 | PubMed |
| 5 | 29352997 | Microglia and Neonatal Brain Injury. | Neuroscience | 2019 | https://conductscience.org/library/papers/29352997 | PubMed |
| 6 | 34975308 | Early Toll-like receptor 4 inhibition improves immune dysfunction in the hippocampus after hypoxic-ischemic brain damage. | Int J Med Sci | 2022 | https://conductscience.org/library/papers/34975308 | PubMed |
| 7 | 38042110 | TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38042110 | PubMed |
| 8 | 41581784 | Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy: Clinical Report. | Pediatrics | 2026 | https://conductscience.org/library/papers/41581784 | PubMed |
| 9 | 38937163 | Effects of pain, sedation and analgesia on neonatal brain injury and brain development. | Semin Perinatol | 2024 | https://conductscience.org/library/papers/38937163 | PubMed |
| 10 | 35259691 | Human bone marrow mesenchymal stem cells-derived exosomes protect against nerve injury via regulating immune microenvironment in neonatal hypoxic-ischemic brain damage model. | Immunobiology | 2022 | https://conductscience.org/library/papers/35259691 | PubMed |
| 11 | 25686754 | The role of inflammation in perinatal brain injury. | Nat Rev Neurol | 2015 | https://conductscience.org/library/papers/25686754 | PubMed |
| 12 | 33991400 | Microglia-leucocyte axis in cerebral ischaemia and inflammation in the developing brain. | Acta Physiol (Oxf) | 2021 | https://conductscience.org/library/papers/33991400 | PubMed |
| 13 | 41784867 | Time-resolved urinary proteomics reveals heme-associated oxidative stress responses in neonatal hypoxic-ischaemic encephalopathy. | Mol Cell Pediatr | 2026 | https://conductscience.org/library/papers/41784867 | PubMed |
| 14 | 33452162 | Loss of Wip1 aggravates brain injury after ischaemia/reperfusion by overactivating microglia. | Stroke Vasc Neurol | 2021 | https://conductscience.org/library/papers/33452162 | PubMed |
| 15 | 41534673 | Purα overexpression mitigates neonatal hypoxic-ischemic brain damage by inhibiting neuronal pyroptosis via the P2X7R/NLRP3/Caspase-1 pathway. | Brain Res Bull | 2026 | https://conductscience.org/library/papers/41534673 | PubMed |
| 16 | 33269748 | TP53-induced glycolysis and apoptosis regulator alleviates hypoxia/ischemia-induced microglial pyroptosis and ischemic brain damage. | Neural Regen Res | 2021 | https://conductscience.org/library/papers/33269748 | PubMed |
| 17 | 41365065 | Aucubin attenuates neonatal hypoxic-ischemic brain injury by suppressing NLRP3 inflammasome-mediated microglial pyroptosis. | Bioorg Chem | 2026 | https://conductscience.org/library/papers/41365065 | PubMed |
| 18 | 41885253 | Microglial Inhibition Promotes Proliferation and Differentiation of Neural Stem Cells via STAT3/SDF-1/CXCR4 Signaling Pathway in Hypoxic-Ischemic Encephalopathy. | Glia | 2026 | https://conductscience.org/library/papers/41885253 | PubMed |
| 19 | 38715091 | CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/38715091 | PubMed |
| 20 | 41022342 | Human umbilical cord blood cells-secreted exosomal MFG-E8 regulates microglia polarization and ameliorates hypoxic-ischemic brain damage in neonatal rats by SOCS3/STAT3 axis. | Arch Biochem Biophys | 2025 | https://conductscience.org/library/papers/41022342 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42840552
GET https://conductscience.org/api/papers/v1/42840552/references?page=2